119 related articles for article (PubMed ID: 8733245)
21. [Perioperative management for transurethral resection of bladder tumor (TUR-Bt) associated with congenital antithrombin III deficiency].
Mizuno J; Kato S; Namai S; Komiya Y; Kuwana Y; Morita S
Masui; 2009 Dec; 58(12):1524-7. PubMed ID: 20055199
[TBL] [Abstract][Full Text] [Related]
22. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
[TBL] [Abstract][Full Text] [Related]
23. Effects of a combined antithrombin III and protein C supplementation in porcine acute endotoxic shock.
Fourrier F; Jourdain M; Tournoys A; Gosset P; Mangalaboyi J; Chopin C
Shock; 1998 Nov; 10(5):364-70. PubMed ID: 9840653
[TBL] [Abstract][Full Text] [Related]
24. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Abildgaard U; Larsen ML
Thromb Res; 1984 Aug; 35(3):257-66. PubMed ID: 6547786
[TBL] [Abstract][Full Text] [Related]
25. [Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency].
Gerhards H
Tierarztl Prax; 1987; 15(1):47-55. PubMed ID: 3590168
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia.
Emerson TE; Fournel MA; Redens TB; Taylor FB
Am J Med; 1989 Sep; 87(3B):27S-33S. PubMed ID: 2679067
[TBL] [Abstract][Full Text] [Related]
27. Influence of antithrombin III on coagulation and inflammation in porcine septic shock.
Dickneite G; Leithäuser B
Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1566-72. PubMed ID: 10364091
[TBL] [Abstract][Full Text] [Related]
28. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
Bokarev IN; Butorov VN; Loginov LE
Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
[No Abstract] [Full Text] [Related]
29. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
[No Abstract] [Full Text] [Related]
30. High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation.
Eskici ZM; Açıkgöz Ş; Pişkin N; Mungan G; Can M; Güven B; Köktürk F
Acta Biochim Pol; 2012; 59(4):561-6. PubMed ID: 23094260
[TBL] [Abstract][Full Text] [Related]
31. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
32. [Fibrin monomer assay].
Kobayashi H; Matsuo M; Ikeguchi K; Yamamoto K; Kario K; Matsuo T
Rinsho Byori; 1991 Jul; 39(7):689-93. PubMed ID: 1920860
[TBL] [Abstract][Full Text] [Related]
33. Roles of protein C, protein S, and antithrombin III in acute leukemia.
Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
[TBL] [Abstract][Full Text] [Related]
34. Neonatal antithrombin III deficiency.
Manco-Johnson MJ
Am J Med; 1989 Sep; 87(3B):49S-52S. PubMed ID: 2679071
[TBL] [Abstract][Full Text] [Related]
35. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.
Frantzen Handeland G; Abildgaard U; Aasen AO
Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of disseminated intravascular coagulation in dogs admitted to an intensive care unit.
Bateman SW; Mathews KA; Abrams-Ogg AC; Lumsden JH; Johnstone IB; Hillers TK; Foster RA
J Am Vet Med Assoc; 1999 Sep; 215(6):798-804. PubMed ID: 10496131
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of antithrombin III deficiency in blood donors selected for personal or familial history of venous thrombosis.
Finazzi G; Radice E; Armato A; Barbui T
Ric Clin Lab; 1985; 15(2):173-6. PubMed ID: 4059797
[TBL] [Abstract][Full Text] [Related]
38. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
39. Clinical application of a chromogenic substrate method for determination of factor VIII activity.
Rosén S; Andersson M; Blombäck M; Hägglund U; Larrieu MJ; Wolf M; Boyer C; Rothschild C; Nilsson IM; Sjörin E
Thromb Haemost; 1985 Dec; 54(4):818-23. PubMed ID: 3937277
[TBL] [Abstract][Full Text] [Related]
40. A colorimetric assay for plasma antithrombin III using a new synthetic peptide substrate (PS-915).
Asai K; Asai M
Clin Chim Acta; 1984 Dec; 144(2-3):163-71. PubMed ID: 6397281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
